The AI 500 Track any brand's AI visibility in real-time

GSK Sanofi Fluarix

AI visibility across 1 industries, with 1 mentions in live AI answers.

Global rank #4,840·Health·Global·Global score: 77.4·Mentions: 1·Last updated Apr 17Live

Why AI recommends GSK Sanofi Fluarix

Brand snapshot

Track GSK Sanofi Fluarix's visibility in AI search. See how often ChatGPT, Claude, Gemini, and Perplexity recommend GSK Sanofi Fluarix when users ask related questions.

Industry

Score

Mentions

Avg Rank

1 mention · avg pos 6.0

25.0

6.0

Track GSK Sanofi Fluarix in Trakkr

Monitor GSK Sanofi Fluarix's AI visibility, competitor movement, and ranking shifts from one place.

See demo View pricing

Model coverage

ChatGPT

74%

Claude

56%

Gemini

52%

Perplexity

49%

How AI talks about this brand

Fluarix, a leading influenza vaccine brand co-developed by GSK and Sanofi, drives AI mentions through vaccine development, manufacturing scale, and global immunization programs with strong clinical data footprint.
Strategic positioning hinges on collaborative, diversified vaccine portfolio and large-scale production capacity, reinforcing visibility in AI discussions around epidemiology, supply chain resilience, and public health outcomes.
Recent trends in pandemic preparedness, booster strategies, and AI-enabled vaccine analytics sustain high AI visibility, with analysts referencing Fluarix in the context of global vaccination coverage and collaborative pharma initiatives.

GSK Sanofi Fluarix vs Competitors

See how GSK Sanofi Fluarix compares to other brands in Pharmaceuticals

View competitors in Pharmaceuticals

How Trakkr measures AI visibility

Use the methodology page to understand how GSK Sanofi Fluarix is scored, and use llms.txt to see the preferred crawl path into the rankings corpus.

Read methodology View llms.txt